During gene expression, mRNA molecules are transcribed in the nucleus, transported to the cytoplasm where they serve as templates for translation, and then finally degraded. This process is essential in order to produce proteins in a timely manner, and it enables adaptation to new environmental conditions. mRNA degradation and translation are often studied as independent events; however, an increasing amount of evidence suggests that the two processes are interconnected 1, 2 . The 5′ ends of mature eukaryotic mRNA molecules are protected by a cap structure that is removed before 5′-3′ mRNA degradation, exposing a 5′ phosphate group. Recent studies in S. cerevisiae have shown that mRNAs can undergo 5′-3′ exonucleolytic decay while they are associated with ribosomes 3 , and that this co-translational decay is widespread, resulting in a genome-wide footprint of the last translating ribosomes' positions 4 . Here we present 5PSeq, which is an approach that leverages the intimate relationship between 5′-3′ mRNA degradation and translation to infer the genomewide position of elongating ribosomes in vivo 4 (Fig. 1) .
Development of the protocol 5PSeq originated from our previous efforts directed at studying the heterogeneity of transcript isoforms [5] [6] [7] . In particular, we developed 5PSeq as a negative control for the genome-wide identification of transcription start sites based on tobacco acid pyrophosphatase (TAP) treatment, both independently (PROCEDURE Step 4) and jointly with the identification of polyadenylation (poly(A)) sites (TIF-seq 5, 6 ). During this process, our approach converged with independently developed methods to study mRNA degradation intermediates [8] [9] [10] [11] [12] [13] (see ' Comparison with other methods' below).
On analyzing the data from 5′-3′ mRNA degradation intermediates, we realized that their abundance was not random, but caused by an underlying biological process. In particular, we have recently shown that naturally occurring 5′P mRNA decay intermediates display a characteristic 3-nt periodicity pattern in coding regions 4 (Fig. 2) . This pattern can be observed both in total RNA extracts and in polyribosomes isolated by ultracentrifugation from sucrose gradients. Perturbation of the translation process by addition of drugs, such as cycloheximide that inhibits translation elongation, alters the observed 5′P degradation pattern. Through extensive testing, we have shown that this process is caused by exonucleolytic 5′-3′ decay that affects mRNAs that are still associated with ribosomes 4 . Specifically, the exonuclease Xrn1 follows the last translating ribosome, producing a progressive in vivo footprint of its 5′ position on the mRNA. By analyzing the abundance of 5′P mRNA molecules, we can detect novel and previously described codon-specific translation pause sites. For example, 5PSeq can detect an accumulation of ribosomes at the rare proline codon CCG (Fig. 2a) . This translation pause causes an accumulation of 5′P mRNA degradation intermediates 17 nt upstream of the pausing site (the area protected by the last elongating ribosome). Interestingly, this protection 17 nt upstream of the pausing site is diffused if the samples are treated with cycloheximide (Fig. 2a) .
To confirm that 5PSeq can detect translation pauses at individual codons, we induced a general accumulation of ribosomes at histidine codons by adding an inhibitor of histidine biosynthesis. By using this approach, we showed that 5PSeq clearly detects translation pauses at the respective codons, as well as an accumulation of up to three ribosomes regularly spaced upstream of the histidine pausing sites.
In summary, by measuring changes in the quantity of the 5′ ends of mRNA degradation intermediates, 5PSeq can detect translation pauses at the level of elongation and termination, both under normal conditions and when induced by environmental changes. The 5PSeq approach does not require in vitro RNA digestion, and it offers an easy and efficient complement to existing protocols for studying ribosome dynamics in vivo 14, 15 . ligation event. After the RNA ligation step, it is important to check the integrity of the RNA and to ensure that the analysis focuses on the naturally present mRNA degradation intermediates. We therefore measure rRNA integrity by agarose gel or Bioanalyzer as an indicator of RNA quality throughout the process 5 .
Once an oligo-ligated RNA sample has been obtained, it is essential to remove abundant 5′P non-mRNA molecules that would otherwise constitute the majority of the sequencing reads. Important contaminants include rRNA molecules, which constitute the majority of 5′P molecules in the cell. To decrease the presence of contaminant rRNA molecules, we routinely apply either a poly(A) selection strategy to enrich for the short poly(A) tails present on the partially deadenylated mRNA molecules or an rRNA depletion strategy (Step 13). The poly(A) selection approach allows processing of more starting RNA material (as rRNAs do not bind to the beads), whereas the starting RNA amount in an rRNA depletion scheme is limited by the amount of rRNA that can be efficiently depleted from the sample. However, the poly(A)-dependent approach will preferentially enrich those mRNA degradation intermediates that are still partially polyadenylated, whereas the rRNA depletion approach is independent of any remaining poly(A) tails. It is also important to point out that, even after rRNA depletion, reads originating from rRNAs, tRNAs or snRNAs still constitute a substantial part of the obtained reads. Specifically in the poly(A) enrichment approach, rRNA constitutes 90% of the reads, whereas when using an rRNA depletion approach, it only accounts for 1% of the sequencing reads. As the cost associated with the selective removal of rRNAs can, in some cases, exceed the cost of the sequencing itself, each user should consider whether poly(A) enrichment or rRNA depletion (more expensive but cleaner) is most appropriate for their needs.
Sequencing library construction.
Once the sample has been subjected to selective ligation and enriched for mRNA degradation intermediates, RNA molecules are fragmented by heat in the presence of magnesium and reverse transcribed (Steps 22-34). cDNA molecules containing the RNA-ligated oligo sequence are primed using biotinylated oligos to allow streptavidin-based purification at subsequent steps, and they are used as templates for the generation of double-stranded cDNA (Steps 35-39). Biotinylated double-stranded cDNA is bound to streptavidin beads, and an Illumina library is constructed (or a library compatible with the sequencing platform of choice); in our case, we use a modified Illumina procedure to generate libraries bound to magnetic beads 6, 7 . Library preparation includes DNA blunt ending, dA addition and adapter ligation. The library remains bound to streptavidin beads throughout all steps (Steps 40-67). During the enrichment PCR (Step 68), custom PE2_MPX oligos ( Table 1 ) are used to introduce a sample-specific barcoded index that enables multiplexing of different samples in the same sequencing lane. Sequencing is performed in an Illumina HiSeq 2500 machine using a 50-nt single-end read (8 nt for the UMI and 42 nt to identify the region) and using a 6-nt indexing read to identify the multiplexed the samples.
Applications of the method
We have shown that 5PSeq can detect ribosomal pauses in both S. cerevisiae and Schizosaccharomyces pombe 4 . Of these two organisms, S. cerevisiae produces a clearer translation-dependent 3-nt periodicity pattern, and therefore it requires lower sequencing depth to identify translation pauses. Multiple factors could be responsible for this difference. For example, different velocity of translation or the 5′-3′ degradation machinery could affect kinetic competition and thus the sharpness of the 3-nt periodicity pattern caused by co-translational degradation. Alternatively, the fact that S. pombe has a significantly longer mRNA half-life than S. cerevisiae 19 could imply that, compared with mature mRNA, the abundance of degradation intermediates is lower in S. pombe, and thus it is more difficult to detect. The coexistence of different transcript isoforms produced by alternative splicing, a phenomenon more common in S. pombe, could further diffuse the pattern. Specifically, transcripts containing alternative exons that encode proteins translated using different reading frames will produce protection patterns displaced by 1 or 2 nt. When these reads are mapped to the genome, the 3-nt periodicity pattern will appear less marked. Preliminary experiments with human cells (V.P., W.W. and L.M.S., unpublished data) suggest that, although a subtle codon pattern is present in degradation intermediates, further optimization and higher sequencing coverage would be needed to efficiently detect translation pauses. This could be because of similar factors as those described for S. pombe. The longer halflife of mammalian mRNAs could lead to a decreased abundance of degradation intermediates relative to mature molecules and other 5′P molecules, making it more challenging to detect the products of co-translational degradation. The existence of other RNA degradation or processing mechanisms could also produce alternative 5′P molecules that would diffuse the co-translational 3-nt ribosome protection pattern. Theoretically, 5PSeq could also be used to study the rate of mRNA decay. However, the abundance of 5′P mRNA degradation intermediates would depend not only on the mRNA half-life but also on other factors such as gene-specific translation activity, the preferred degradation pathway (e.g., more prone to 5′-3′ or 3′-5′ decay), RNA-binding protein association and so on. Therefore, we have focused our analysis on the 3-nt pattern (i.e., difference between peaks and valleys) that already corrects for the abundance of mRNA degradation intermediates at the gene level.
Comparison with other methods
Currently, ribosome profiling is the most widely used method to study ribosome dynamics 14, 20 . Although this approach has significantly advanced the study of translation and can be applied to many diverse organisms 14, [20] [21] [22] [23] [24] [25] [26] , it requires in vitro manipulation of ribosomal fractions and often also the use of translation inhibitors that may alter ribosomal protection patterns 22, 27 . In some cases, translation inhibitors, such as cycloheximide, are necessary to freeze ribosomes in their positions during the in vitro processing steps (e.g., RNA extraction, sucrose fractionation and RNase I footprinting) 14 . In yeast, recent optimizations made to the ribosome profiling method have decreased or even eliminated the use of translational inhibitors and improved the collection of cells using filtration and flash-freezing. These optimizations markedly improved the quality of ribosome profiling data 28, 29 . However, ribosome profiling requires extensive manipulation of the polyribosomal fractions, as well as in vitro RNase treatment, to obtain ribosomal footprints. In addition, the precision of ribosome profiling is based on the assumption that ribosomes do not move during the RNase treatment, either because of the presence of translational inhibitors or the lack of substrates necessary for translation elongation. Therefore, rapid approaches to infer ribosome dynamics in vivo are needed. In this respect, 5PSeq represents a rapid and complementary method that requires access solely to the mRNA within a cell. When analyzing data from 5PSeq and ribosome profiling, it is important to remember that these two methods focus on two different, although related, subpopulations of RNA molecules. Ribosome profiling analyzes the bulk of mRNAs bound by ribosomes, whereas 5PSeq focuses on the subpopulation of mRNAs undergoing 5′-3′ degradation. The analysis of changes in 5′P degradation intermediate distribution across conditions can thereby be used as a proxy for changes in global ribosome occupancy 4 ; however, in our opinion, 5PSeq is better suited to the study of ribosome protection patterns. Specifically, the main advantage of 5PSeq is that it allows the study of in vivo codonspecific ribosome protection patterns in a drug-free environment and without in vitro RNA digestion. Both ribosome profiling 14, 20 and 5PSeq are better suited to the analysis of groups of genes using metagene-based profiles in which the information of multiple genomic loci can be combined to obtain cleaner signals and to increase sequencing coverage (Fig. 2a) . One advantage of 5PSeq is that, as the footprinting is only on the 5′ side, it allows the generation of substantially longer sequencing reads that lead to improved mapping and identification of uniquely aligned reads. In addition, 5PSeq can even be applied to RNA samples that were previously isolated and stored, as we did in our previous publication 4 .
With regard to mRNA decay, alternative methods have previously been described to study mRNA degradation intermediates. For example, parallel analysis of RNA ends (PARE) 30 was developed to study the RNA degradome and to identify miRNA targets in a high-throughput manner. Much effort has been devoted to identifying mRNA endonucleolytic cleavage sites using 5′-3′ RNA degradation mutants in plants [8] [9] [10] , yeast 11 and mammals 12 . These studies have provided interesting insights into RNA metabolism; however, until recently it was assumed that 5′P mRNA degradation products arose from a random process, from which no biological information could be extracted 4 . Although the aforementioned methods were not designed for the study of co-translational degradation, in principle they should be able to identify the same 5′P molecules detected by 5PSeq. The main technical difference is that most previous protocols are based on the production of full-length cDNA using a reverse transcription approach that primes on the poly(A) sequence and then reaches the 5′P site 30 . This technical difference is likely to cause an increased bias toward the amplification of short degradation intermediates with substantially longer poly(A) tails, but it should otherwise be able to retrieve similar information as 5PSeq. Experimental design Enrichment for mRNA degradation intermediates. A key step of the protocol is to eliminate from the sample common contaminants, such as rRNA or tRNAs, that constitute the bulk majority of 5′P in the cell. We use either a poly(A) enrichment of the fragmented mRNA molecules or a selective depletion of rRNA molecules. Each approach has its respective advantages and limitations (see 'Overview of the procedure' above). However, any extra depletion strategy that further decreases contaminant abundance, while maintaining the complexity of the 5′P mRNA degradation intermediates, will improve the number of usable reads obtained per sequencing reaction. Alternatives that could be tested include double poly(A) purification, as performed in other approaches 9, 13 . However, in our hands, a selective removal of rRNAs produces cleaner samples, although the main limitation of their use is the high cost associated with these treatments.
Variations of the 5PSeq approach. We have designed the 5PSeq protocol as a modular scheme. By changing the RNA pretreatments, we can selectively focus on different RNA subpopulations based on their 5′ modification (PROCEDURE Step 4 and Figs. 3,4) . In this respect, by performing an oligocapping approach 31, 32 , including phosphatase treatment followed by removal of the cap, we can focus on the previously capped molecules 5, 6 . To map 5′-cap mRNAs, we have used both the classical TAP treatment and two new enzymes that are also able to remove the 5′ cap. In our hands, Cap-Clip (CellScript) performed slightly better than a decapping pyrophosphohydrolase (Tebu-bio) producing lower background (Fig. 4) . However, it is important to note that we performed the experiments with the first produced batches for those enzymes, and further improvement of their activity could be expected in the near future.
Controls.
To account for any possible intrinsic biases in RNA ligation and library construction, we recommend performing a random fragmentation control, in which RNA samples are chemically fragmented and re-phosphorylated before being processed by 5PSeq (PROCEDURE Step 4 and Fig. 3c ). This control will Step 4 for specific details. CAP, the 5′ cap modification; P, a phosphate group; OH a hydroxyl group; N8, eight random nucleotides that serve as a unique molecular identifier. enable any alteration that occurs because of the RNA sequence itself rather than the translation process to be eliminated.
Limitations
The main limitation of the 5PSeq approach is that, as it focuses on the subpopulation of mRNAs undergoing degradation, any changes affecting this process will be directly captured. Therefore, 5PSeq cannot, for example, be used to study ribosome dynamics in an xrn1 strain, as it does not have the machinery necessary to produce the in vivo ribosome footprint. For the same reason, any other genetic modifications or environmental perturbations that affect RNA degradation will influence the observed 5PSeq protection pattern independently of the translation process. Similarly, any regulation at the translational level that occurs before the removal of the 5′ cap would not be observed by this approach. However, we have recently shown that, at least in yeast, the movement of the last translating ribosome during co-translational mRNA decay is a good proxy for general ribosome dynamics 4 . Another important limitation of 5PSeq and ribosome profiling is that both methods measure ribosome protection and not necessarily protein production. After oxidative stress, for example, there is an accumulation of mRNA in polyribosomes, leading to increased ribosome protection, but not protein synthesis 4, 33, 34 . Although the variation of 5PSeq protection can be used as a proxy for ribosome occupancy 4 , in general we do not recommend the use of 5PSeq to measure absolute translation rates, as the abundance of 5′P molecules depends both on ribosome occupancy and mRNA stability. However, 5PSeq is well suited for the identification of position-specific protection patterns, as the comparison between peaks and valleys of codon protection (Fig. 2a) normalizes for the total abundance of degradation intermediates.
Finally, as 5PSeq focuses on a small subpopulation of molecules, it is prone to producing libraries with limited complexity. To control for this problem, we have included random barcodes in the protocol that serve as UMIs (rP5_RND oligo used in
Step 10). To ensure that the library complexity is as high as possible, we recommend starting with large amounts of total RNA (minimum of 5 µg of total RNA). In addition, any further purification steps that decrease the abundance of contaminant rRNA molecules will further improve the number of usable reads.
MaterIals

REAGENTS
Total RNA extracted from the sample of interest (concentration should be at least 2 µg µl −1 )  crItIcal We extract total RNA from mid-log (optical density at 600 nm (OD 600 ) 0. 
REAGENT SETUP Preparation of P7MPX annealed adapter This adapter is used at
Step 60 to generate the Illumina-compatible sequencing library. Mix oligos P7MPX_linker_for and P7MPX_linker_for ( 
RNasin plus 1
Total 50  crItIcal step It is possible to add in vitro-transcribed RNA controls in this step 4 . However, it is not essential, as sharp transcription start peaks are not expected. If in vitro-transcribed spike-ins are used, their 5′ ends should be modified to contain 5′P molecules (via CIP treatment followed by T4 PNK treatment, as detailed in Steps 4A and 4C).  crItIcal step In all the steps involving RNA manipulation, it is crucial to work in an RNase-free environment, to use gloves and to maintain the samples on ice whenever possible.  crItIcal step We have successfully produced 5PSeq libraries starting with as little as 5 µg of total RNA. However, as the 5′ phosphorylated molecules are of relatively low abundance, decreasing the starting RNA amount usually leads to a decreased library complexity and an increased number of PCR duplicates.
2| Add 6 µl of TURBO DNase inactivation reagent and mix the contents by gently tapping the tubes. Incubate the samples for 5 min at RT with occasional mixing.
3|
Centrifuge the samples at 16,000g at RT for 2 min, and recover the supernatant.  crItIcal step Keep an aliquot (e.g., 0.5 µl) from every step involving RNA to check the rRNA integrity on a Bioanalyzer RNA gel or an agarose gel after the specific manipulation. ? troublesHootInG
4|
To capture different subpopulations of mRNA molecules, perform the appropriate RNA treatment(s) (Fig. 3) before single-stranded RNA ligation, as indicated below. All steps assume input RNA amounts of 10-50 µg. 
6|
Centrifuge the sample for 30 min at 14,000g and at 4 °C to precipitate the RNA.
7|
Wash the pellet by adding 300 µl of ice-cold 70% (vol/vol) ethanol.
8|
Centrifuge the sample containing the 70% (vol/vol) ethanol for 10 min at 14,000g and at 4 °C.
9|
Remove the remaining ethanol, air-dry the pellet and resuspend the pellet in 3.5 µl of RNase-free water.  crItIcal step All ethanol should be removed before resuspending any DNA or RNA precipitate in water. However, excessive drying of the pellet will make its resuspension difficult, and therefore it should be avoided.  crItIcal step Do not add the PEG supplied with the T4 RNA ligase 1, as it will cause RNA precipitation during the ligation at 16 °C.  crItIcal step The single-stranded RNA ligation is an inefficient step. Always use DNA/RNA oligos with at least the last eight bases being rNTPs. Any further optimization of this step will increase the overall efficiency of the 5PSeq protocol.
11|
Incubate the sample overnight for 16 h at 16 °C.
12|
Increase the volume to 100 µl with RNase-free water.  crItIcal step Run an Agilent RNA Bioanalyzer gel comparing the input (from Step 3) and ligated RNA samples. If substantial degradation is observed (e.g., an excess of short-length RNAs or the 18S is more intense than the 26S), the samples should be discarded. ? troublesHootInG enrichment of the sample for polyadenylated mrna molecules • tIMInG 40 min  crItIcal Here we describe poly(A) enrichment. However, it is possible to use an rRNA depletion strategy. We have successfully used the Ribo-Zero gold rRNA removal kit (yeast) using 5 µg of starting RNA material (Illumina, cat. no. MRZY1306). Do not use an rRNA depletion method based on the depletion of 5′P molecules (such as the Terminator 5′phosphate-dependent exonuclease, Epicentre), as that will prevent the detection of any 5′P degradation intermediates. 13| Prepare Dynabeads oligo (dT) 25 according to the manufacturer's instructions. First, resuspend the beads and transfer 100 µl of beads into a 1.5-ml tube.
14| Place the 1.5-ml tubes in the magnetic stand and wait until the solution is clear (~2 min). Remove the supernatant and wash the beads with 100 µl of binding buffer.
15|
Place the 1.5-ml tubes in the magnetic stand and wait until the solution is clear (~2 min). Remove the supernatant and resuspend the beads in 100 µl of binding buffer. Keep the washed oligo (dT) 25 until required at RT (Step 17).
16|
Add 100 µl of binding buffer to the 100-µl ligated RNA sample (from Step 12), and incubate the samples for 2 min at 65 °C to denature the mRNAs. Immediately place the samples on ice. 
23|
Incubate the sample at 80 °C for 5 min, and then immediately place it on ice.
24| Purify the sample using 2× volumes of HighPrep beads, as described by the manufacturer. Add 50 µl of HighPrep beads and mix the sample using the pipette. Wait until the sample binds the beads by incubating at RT for 5 min.  crItIcal step All volumes of HighPrep beads refer to bead slurry, as described in the manufacturer's protocol. 30| Mix the sample and add 2 µl of SuperScript II reverse transcriptase to each sample.
31|
Incubate the sample at 25 °C for 10 min, 42 °C for 50 min and inactivate it at 70 °C for 15 min. Hold the sample at 4 °C.
32|
Purify the sample using 1.8× volumes of HighPrep beads, as described by the manufacturer. Add 1.8× volumes HighPrep beads and mix the sample using the pipette. Wait until the sample binds the beads by incubating at RT for 5 min. 
42|
Resuspend the beads in 40 µl of 2× bind and wash buffer.  crItIcal step If multiple samples are processed in parallel, it is possible to wash more M-280 streptavidin beads in bulk by increasing the volumes of the previous treatments in a 1.5-ml tube and then transferring the beads to 0.2-ml tubes.
43| Add 40 µl of the generated double-stranded cDNA (from Step 39) to the beads and incubate the tubes on a rotating wheel for 30 min at RT to let the samples bind. Rotation will prevent the beads from settling, but it will not mix the solution.
44| Place the 0.2-ml tubes in the magnetic stand and wait until the solution is clear (~2 min). Remove the supernatant.
45|
Perform four consecutive washes with 200 µl of 1× bind and wash buffer.
46|
Wash the beads with 200 µl of buffer EB.
47|
Resuspend the beads in 20.75 µl of water.  crItIcal step Samples remain bound to the beads because of the streptavidin-biotin interaction.  crItIcal step To decrease sample-handling time, it is possible to directly resuspend the streptavidin-biotin beads containing the sample directly in end repair mix (see Step 48) rather than in water. 70| Place the 0.2-ml tubes in the magnetic stand and wait until the solution is clear (~2 min). Transfer the supernatant containing the PCR-amplified sample to a new 0.2-ml tube. Keep the used streptavidin beads as a backup, storing them at 4 °C in case the PCR needs to be repeated.
71|
Purify the sample using 1.8× volumes of HighPrep beads as described by the manufacturer. Add 90 µl of HighPrep beads and mix the sample using the pipette. Wait until the sample binds the beads by incubating at RT for 5 min.
72| Place the 0.2-ml tubes in the magnetic stand, and wait until the solution is clear (~2 min). Remove the supernatant, and, without letting the beads to dry, perform two consecutive washes with 200 µl of 70% (vol/vol) ethanol.
73|
Remove the ethanol and let the beads dry for 1 min. Elute in 20 µl of buffer EB (10 mM Tris-HCl, pH 8.0).
74| Quantify the produced library by Qubit using the dsDNA HS assay kit, and check the size using a high-sensitivity DNA Bioanalyzer.
? troublesHootInG  pause poInt The sample may be stored for months at −20 °C.
library size selection • tIMInG 30 min 75| Enrich the samples for fragments between 300 and 500 nt using differential binding to HighPrep beads with varying PEG concentrations. Mix equivalent amounts of amplified 5PSeq libraries from
Step 74 (e.g., 50 ng of 12 different libraries to be sequenced in the same lane) in the same tube, and increase the volume to 50 µl.
76|
Add 0.65× volumes of HighPrep beads to the sample to bind the long DNA molecules. For 50 µl of sample, add 32.5 µl of HighPrep beads and mix the sample using the pipette. Wait until the sample binds the beads by incubating at RT for 5 min.
77| Place the 0.2-ml tubes in the magnetic stand and wait until the solution is clear (~2 min). Transfer the supernatant containing the sample of interest to a new tube.  crItIcal step At this point, only very long DNA molecules will be bound to the beads, and the molecules of interest will be in the supernatant. It is possible to keep the beads on the bench with 200 µl of 70% (vol/vol) ethanol for some hours until the presence of the sample of interest in the supernatant has been confirmed by Qubit (Step 80).
78|
Add 0.2× volumes (of the original sample volume) of fresh HighPrep beads to the recovered supernatant (this will raise the PEG concentration to 0.85×). For 50 µl of original sample, add 10 µl of HighPrep beads and mix the sample using the pipette. Wait until the sample binds the beads by incubating at RT for 5 min.
79| Place the 0.2-ml tubes in the magnetic stand and wait until the solution is clear (~2 min). Remove the supernatant, and, without letting the beads dry, perform two consecutive washes with 200 µl of 70% (vol/vol) ethanol.  crItIcal step At this point, only short DNA molecules will be in the supernatant, and the size range of interest will be bound to the beads.
80|
Remove ethanol and let the beads dry for 1 min. Elute in 20 µl of buffer EB and transfer to a 0.2-ml tube.
81|
Check the concentration by Qubit using the dsDNA HS assay kit (ideally there should be more than 1 ng µl −1 per sample), and check the size by using a Bioanalyzer.
82|
Sequence the libraries using single-end 50-bp-long read Illumina sequencing with a 6-nt indexing read to identify the samples.  crItIcal step Depending on the organism of interest, it is possible to increase the sequencing length to increase the number of uniquely mapped reads.
bioinformatics analysis • tIMInG 10 h  crItIcal The downstream data analysis vary depending on the specific bioinformatics pipeline used. Here we provide general recommendations on how the analysis should be performed. 83| De-multiplex the read files using the indexing reads. The latest Illumina BaseSpace software system provides the option to do de-multiplexing and to generate a read file for each sample. Otherwise, tools such as deindexer (https://github.com/ ws6/deindexer) or the 'ShortRead' R package 35 from Bioconductor 36 can be used to de-multiplex the original reads.
84|
Trim the first 8 nt corresponding to the UMI and add them to the read name line. These sequences will be used in a later step to identify unique molecular events and to eliminate amplification bias.  crItIcal step Some aligners trim off the characters after a space in the read name. To avoid losing the UMI sequences after alignment, all space characters in the read name should be removed or replaced. This can be done with the ShortRead R package 35 from Bioconductor 36 .
85|
Align the remaining reads corresponding to the 5′ end of the mRNA molecule of interest to the reference genome using Novoalign V3.02.05 (http://www.novocraft.com) with default parameters.  crItIcal step In 5PSeq, the mRNA degradation occurs only from the 5′ side; thus, the observed ribosome-protected fragments are much longer than those obtained by ribosome profiling, allowing better mapping to the genome.
86|
Collapse the reads that contain the same UMI sequence and map to the exact same 5′ end location in the genome. Only keep reads representing different unique molecular events for further analysis. Data frames including the genome location of the 5′ end and the number of unique molecules are kept for further functional analysis. This can be done using the 'Rsamtools' R package 37 (http://www.bioconductor.org/packages/2.12/bioc/html/Rsamtools.html) from Bioconductor 36 .  crItIcal step Depending on the sample complexity and the amount of starting material used, the quantity of uniquely mapped molecules may be low. Owing to rRNA contamination and PCR duplicates, if poly(A) selection is used, only ~10% of the total sequencing library reads represent non-rRNA uniquely identified molecules. If an rRNA depletion approach is used, more than 85% of total sequencing reads are uniquely mapped to the reference genome.
? troublesHootInG ? troublesHootInG Troubleshooting advice can be found in table 2.
Unsuccessful experiments with artifactual RNA degradation could lead to the appearance of flat metagene profiles (dotted black line in Fig. 2a) . Annotation-free approaches can also be used to identify regions enriched in 5PSeq reads compared with random fragmented controls. Previous published raw and curated 5PSeq data are deposited at the Gene Expression Omnibus (GEO) with reference number GSE63120, and comparison data for alternative TAP treatments are available under the reference number GSE73819.
